Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours.
Zhang J, Liu R, Gao S, Li W, Chen Y, Meng Y, Liu C, Jin W, Wu J, Wang Y, Hao Y, Yi S, Qing Y, Ge J, Hu X.
Zhang J, et al. Among authors: chen y.
NPJ Breast Cancer. 2023 Apr 18;9(1):28. doi: 10.1038/s41523-023-00522-5.
NPJ Breast Cancer. 2023.
PMID: 37072437
Free PMC article.